Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications

Type 2 diabetes mellitus (T2D) is an established risk factor for multiple cardiovascular diseases including atrial fibrillation (AF). The causal relationship between type 1 diabetes mellitus (T1D) and AF is poorly defined. T1D and AF share many underlying risk factors, but how T1D may promote AF independently of obesity and other features typical of T2D is not known. Here, we critically review the quality of the available clinical evidence specifically linking AF with the distinct characteristics of T1D and evaluate the mechanistic insights from preclinical models. We provide a conceptual overview of candidate contributing players and highlight important gaps in knowledge, unmet clinical needs, and potential therapeutic perspectives.

Authors

Institutions

Publication Details

Journal
Cardiovascular Research
Published
2025-11-26
DOI
https://doi.org/10.1093/cvr/cvaf252
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications

Samuel C. Dudley, Dobromir Dobrev, Florian Bruns, Anke C. Fender et al.
Cardiovascular Research
Atrial Fibrillation Management and Outcomes
article

Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications

Samuel C. Dudley, Dobromir Dobrev, Florian Bruns, Anke C. Fender, Theresa Poppenborg
article en

Abstract

Type 2 diabetes mellitus (T2D) is an established risk factor for multiple cardiovascular diseases including atrial fibrillation (AF). The causal relationship between type 1 diabetes mellitus (T1D) and AF is poorly defined. T1D and AF share many underlying risk factors, but how T1D may promote AF independently of obesity and other features typical of T2D is not known. Here, we critically review the quality of the available clinical evidence specifically linking AF with the distinct characteristics of T1D and evaluate the mechanistic insights from preclinical models. We provide a conceptual overview of candidate contributing players and highlight important gaps in knowledge, unmet clinical needs, and potential therapeutic perspectives.

Cardiovascular ResearchVol. 121(17)
Baylor College of Medicine (US), Montreal Heart Institute (CA), Minneapolis Heart Institute Foundation (US), West German Heart and Vascular Center Essen (DE)
Openalex Percentile: Top 46%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications — Samuel C. Dudley, Dobromir Dobrev, et al. · Cardiovascular Research (2025) | TGRS Research Map | TGRS